N115, EmphyCorp‘s investigational non-steroidal nasal spray for the treatment of interstitial lung diseases (ILDs), has completed a Phase 3 clinical trial requested by the U.S. Food and Drug Administration (FDA) for its new drug application (NDA) in patients with pulmonary fibrosis (PF). EmphyCorp’s proprietary…
EmphyCorp’s N115 Completes Phase 3 Trial for FDA Marketing Application in PF Patients
I don’t have children yet, but like most people, I learned nearly everything I know about parenting from my parents. I grew up watching them and learning from them. I have taken note of their good strategies and of the things I might do differently with my kids. My husband…
Taking Esbriet (pirfenidone) to manage idiopathic pulmonary fibrosis (IPF) does not increase the risk of heart problems or interfere with commonly used cardiovascular medications, an analysis found. Results of the analysis were published in the journal Advances In Therapy in an article titled, “Cardiovascular Risks,…
12 Facts About Pulmonary Fibrosis Prognosis and Life Expectancy
Pulmonary fibrosis is a chronic and progressive lung disease in which the air sacs in the lungs, called the alveoli, become scarred and stiff, making it difficult to breathe and get enough oxygen into the bloodstream. To address some misconceptions about the prognosis of pulmonary fibrosis and life…
As a condition of being placed on a lung transplant list, I had to show that I had social support. My wife was my main caregiver, but she would need a break now and then. Fortunately, several friends offered to help with caregiving duties. However, our need for…
Goal setting is an essential part of a balanced life. Regardless of whether the goals are related to fitness, finances, or learning a new skill, having targets gives you something to work toward and opportunities for improvement. I recently read a post titled, “8 Benefits of Goal Setting,” and…
People with idiopathic pulmonary fibrosis (IPF) and right heart dysfunction may benefit more from a therapy combining Ofev (nintedanib) with sildenafil than from Ofev alone in terms of cardiac health, according to data from a Phase 3 study. The study, “Nintedanib and Sildenafil in Patients with Idiopathic Pulmonary…
The natural product tannic acid has anti-fibrotic effects on cultured human lung fibroblasts and in an in vivo idiopathic pulmonary fibrosis (IPF) mouse model by reducing signals from TGF-beta receptors, a new study has found. The study, “…
Have you ever been in a position in which you wanted to disclose something but were worried about how it would be perceived? Were you concerned that you’d be treated differently as a result of the disclosure? Unfortunately, I’ve been in this position recently, as I continue to navigate the…
At-home use of wearable physical activity trackers and portable spirometry devices may offer a feasible way of evaluating people with idiopathic pulmonary fibrosis (IPF) taking part in clinical trials, a small study suggests. These findings were reported in “Mobile Health Monitoring in Patients with Idiopathic Pulmonary Fibrosis,”…
Your PF Community
Recent Posts
- Amid a sea of data, the PF community is critical in the search for a cure December 23, 2025
- FDA approves Jascayd for adults with progressive pulmonary fibrosis December 23, 2025
- Oral therapy GRI-0621 boosts lung function, repairs tissue in IPF: Data December 17, 2025
- The greatest gift I’ve received wasn’t under the Christmas tree December 16, 2025
- Reversing caregiver roles taught me about emotional presence December 16, 2025
